Delivery Order N6264522D5008-N0018925F0692
- Not listed
- The U.S. Navy Bureau of Medicine and Surgery awarded a $839,484.31 firm fixed price delivery order contract to Center For Disease Detection, LLC for HIV testing services. This contract is part of a larger $55.8 million Indefinite Delivery Indefinite Quantity (IDIQ) contract the company holds with the Navy for infectious disease testing services, including HIV, hepatitis B, hepatitis C, and parvovirus B19 testing. The work will be performed at the contractor's facilities in San Antonio, Texas and...
- The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $3.06 million to Center For Disease Detection, LLC for initial HIV antibody and antigen (HIV AB AG) screening services. The contract, awarded on May 1, 2023, with an ultimate completion date of September 21, 2023, operates on a firm fixed-price basis with no set-aside designation. Center For Disease Detection, a subsidiary of Laboratory Corporation of America Holdings based in San Antonio, Texas, will perform the...
- This is a $4,600,000.00 delivery order contract awarded by the Department of the Navy's Bureau of Medicine and Surgery to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings. The contract is for the provision of "INITIAL HIV AB AG SCREEN" services and has a period of performance through September 21, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Center For Disease Detection, LLC is a...
- This federal contract award to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, is for the provision of medical laboratory testing services to detect the antigens and antibodies of Human Immunodeficiency Virus (HIV), Hepatitis B Surface Antibody (HBsAb), Hepatitis B Surface Antigen (HBsAg), and Hepatitis C Virus (anti-HCV). The award, issued by the U.S. Department of Defense's Readiness Center, has a ceiling value of $958,699.10 and a period of...
- This is a firm fixed price delivery order contract awarded by the Navy Bureau of Medicine and Surgery (BUMED) to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, for HIV testing services. The contract has a ceiling value of $4,658,559.69 and a performance period ending on December 31, 2016. The contract supports the military's efforts to monitor and address HIV prevalence among service members, with the work primarily performed at the contractor's...
- This federal contract, award ID AE130200330, was awarded to Center For Disease Detection, LLC, a subsidiary of Laboratory Corporation of America Holdings, for the provision of infectious disease testing services. The contract, a firm fixed price definitive contract, has a ceiling value of $5,955 and a completion date of June 21, 2005. The work is to be performed in San Antonio, Texas, and includes HIV screening and other diagnostic testing services for various branches of the U.S. military, such...
- The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price delivery order contract to Center For Disease Detection, LLC (CDD) to provide HIV screening tests. The $5,432,766.23 contract has a completion date of June 30, 2018. CDD, a healthcare provider focused on infectious disease diagnostics, is able to leverage the capabilities of its parent company, Laboratory Corporation of America Holdings, to fulfill this contract. The Department of the Navy Bureau of Medicine and...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $1.75 million firm fixed price delivery order to Center For Disease Detection, LLC for INITIAL HIV AB AG SCREEN services. C D D will provide initial HIV antibody and antigen screening to the Navy Medicine Support Command in Bethesda, Maryland under a three-month period of performance concluding on March 31, 2021. As the Navy's medical logistics and readiness agency, the Bureau of Medicine and Surgery utilizes contractors to...
- <p>The Department of the Navy Bureau of Medicine and Surgery awarded a $4.79 million firm fixed price delivery order contract to Center For Disease Detection, LLC, doing business as C D D, for INITIAL HIV AB AG SCREEN. C D D is a subsidiary of Laboratory Corporation Of America Holdings and will perform the work at its facility located at Bethesda, Maryland. The contract period of performance spans from September 22, 2022 through April 30, 2023. No subcontractors were identified.</p>
- The U.S. Army, through the Defense Health Agency, awarded a delivery order valued at $5.96M to Center For Disease Detection, LLC for HIV antibody-antigen combination screening tests. The contract, awarded on February 28, 2024, with an ultimate completion date of February 27, 2025, utilizes firm fixed-price pricing with no set-aside designation. Work will be performed at the contractor's facility in San Antonio, Texas. Center For Disease Detection, a subsidiary of Laboratory Corporation of...
- N6264522D5008Indefinite Delivery Contract
- N6264522D5008-N0018925F0692Delivery Order
The U.S. Navy Bureau of Medicine and Surgery awarded a delivery order valued at $3.54M on September 17, 2025, to Center For Disease Detection, LLC for monthly infectious disease testing services. The contract, which is firm fixed price with no set-aside designation, is scheduled for completion by March 17, 2026, and will be performed in Bethesda, Maryland. Center For Disease Detection, a subsidiary of Laboratory Corporation of America Holdings, specializes in providing diagnostic screening services to military healthcare programs, with particular expertise in HIV antibody and antigen testing for military personnel across multiple branches of service. This delivery order is issued under Center For Disease Detection's larger Indefinite Delivery Indefinite Quantity (IDIQ) contract with the Navy Bureau of Medicine and Surgery, valued at $55.8M over a five-year period extending through September 2027. The underlying IDIQ contract encompasses comprehensive infectious disease testing services including HIV, hepatitis B, hepatitis C, and parvobirus B19 screening, with monthly processing capacity of 60,000 to 90,000 specimens from over 1,300 worldwide military locations. The company's established infrastructure and track record supporting military medical readiness initiatives position it as a critical provider of diagnostic services for the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5m | 9/15/25 |